81 – 90 of 327
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Measuring FVIII activity of glycopegylated recombinant factor VIII, N8-GP, with commercially available one-stage clotting and chromogenic assay kits : A two-centre study
- Contribution to journal › Article
-
Mark
Anti-factor VIII antibodies in brothers with haemophilia A share similar characteristics
- Contribution to journal › Article
-
Mark
Plasma products do not solve the inhibitor problem
- Contribution to journal › Debate/Note/Editorial
-
Mark
The impact of clinical practice on the outcome of central venous access devices in children with haemophilia
- Contribution to journal › Article
-
Mark
Preference-based valuation of treatment attributes in haemophilia A using web survey
- Contribution to journal › Article
- 2016
-
Mark
BAY 81-8973 safety and efficacy for prophylaxis and treatment of bleeds in previously treated children with severe haemophilia A: results of the LEOPOLD Kids Trial.
- Contribution to journal › Article
-
Mark
Association of peak factor VIII levels and area under the curve with bleeding in patients with haemophilia A on every third day pharmacokinetic-guided prophylaxis.
- Contribution to journal › Article
-
Mark
Dosing regimens, FVIII levels and estimated haemostatic protection with special focus on rFVIIIFc.
(2016) In Haemophilia
- Contribution to journal › Article
-
Mark
Evaluating outcome of prophylaxis in haemophilia: objective and self-reported instruments should be combined.
(2016) In Haemophilia
- Contribution to journal › Article
-
Mark
Hypertension, haematuria and renal functioning in haemophilia - a cross-sectional study in Europe
- Contribution to journal › Article
